These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 26800187

  • 1. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
    Klimek L, Mullol J, Hellings P, Gevaert P, Mösges R, Fokkens W.
    Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
    [Abstract] [Full Text] [Related]

  • 2. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE, Meltzer EO.
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [Abstract] [Full Text] [Related]

  • 3. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
    Bousquet J, Bachert C, Bernstein J, Canonica GW, Carr W, Dahl R, Demoly P, Devillier P, Hellings P, Fokkens W, Klimek L, Lieberman P, Meltzer E, Price D, Ryan D, Wahn U.
    Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
    [Abstract] [Full Text] [Related]

  • 4. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA, Jacobsen C, Christensen ME.
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L, Demoly P, Price D.
    Expert Rev Clin Pharmacol; 2016 Apr; 9(5):705-14. PubMed ID: 26839083
    [Abstract] [Full Text] [Related]

  • 6. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B, Sedaghat AR, Caldwell-Tarr A, Dufour R.
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N.
    BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578
    [No Abstract] [Full Text] [Related]

  • 9. Managing rhinitis: Strategies for improved patient outcomes.
    Carr WW, Nelson MR, Hadley JA.
    Allergy Asthma Proc; 2008 Apr 24; 29(4):349-57. PubMed ID: 18702880
    [Abstract] [Full Text] [Related]

  • 10. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L, Berger WE, Bousquet J, Keith PK, Smith P, Sole D, Scadding G, Kuhl HC, Nguyen DT, Kopietz F, Koltun A.
    Int Arch Allergy Immunol; 2021 Apr 24; 182(11):1026-1035. PubMed ID: 34082425
    [Abstract] [Full Text] [Related]

  • 11. Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis.
    Sousa-Pinto B, Vieira RJ, Brozek J, Cardoso-Fernandes A, Lourenço-Silva N, Ferreira-da-Silva R, Ferreira A, Gil-Mata S, Bedbrook A, Klimek L, Fonseca JA, Zuberbier T, Schünemann HJ, Bousquet J.
    J Allergy Clin Immunol; 2024 Aug 24; 154(2):340-354. PubMed ID: 38685482
    [Abstract] [Full Text] [Related]

  • 12. An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel.
    Lipworth B, Newton J, Ram B, Small I, Schwarze J.
    NPJ Prim Care Respir Med; 2017 Jan 23; 27(1):3. PubMed ID: 28115736
    [Abstract] [Full Text] [Related]

  • 13. Clinical practice guideline: Allergic rhinitis.
    Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, Dawson DE, Dykewicz MS, Hackell JM, Han JK, Ishman SL, Krouse HJ, Malekzadeh S, Mims JW, Omole FS, Reddy WD, Wallace DV, Walsh SA, Warren BE, Wilson MN, Nnacheta LC, Guideline Otolaryngology Development Group. AAO-HNSF.
    Otolaryngol Head Neck Surg; 2015 Feb 23; 152(1 Suppl):S1-43. PubMed ID: 25644617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacotherapy of allergic rhinitis: current options and future perspectives.
    Ridolo E, Montagni M, Melli V, Braido F, Incorvaia C, Canonica GW.
    Expert Opin Pharmacother; 2014 Jan 23; 15(1):73-83. PubMed ID: 24219793
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacotherapy for allergic rhinitis.
    Platt M.
    Int Forum Allergy Rhinol; 2014 Sep 23; 4 Suppl 2():S35-40. PubMed ID: 25182353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
    Klimek L, Bousquet J, Price D.
    Expert Opin Drug Saf; 2016 Jan 23; 15(1):117-29. PubMed ID: 26581312
    [Abstract] [Full Text] [Related]

  • 20. Real-Life Effectiveness of MP-AzeFlu (Dymista®) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale.
    Stjärne P, Nguyen DT, Kuhl HC.
    Pragmat Obs Res; 2023 Jan 23; 14():1-11. PubMed ID: 36628265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.